Nathalie Levasseur
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| First-Line Sacituzumab Govitecan in Advanced Untreated Triple-Negative Breast Cancer Patients. (NCT07299409) | Nathalie Levasseur | 2025-12-01 |
Track Nathalie Levasseur automatically
Every clearance here is in the API, with alerts when new ones post.